407
person
Megan van der Horst, PhD
Megan van der Horst, PhD, was an associate from 2021 to 2022 at the Milken Institute Center for S
trategic Philanthropy. She worked on the Center’s biomedical team, where she conducted research into ALS scientific and funding landscapes.
+ Read More
person
Justin Sun
report
State Technology and Science Index 2022
The State Technology and Science Index (STSI) provides a benchmark for evaluating the knowledge eco
nomies of all 50 US states.
+ Read More
report
The Current Landscape of the Science of Patient Input
In the last decade, FasterCures and many stakeholders across the biomedical research ecosystem have
driven initiatives to ensure that patients’ perspectives and input are appropriately represented across the product-development continuum and post-approv
+ Read More
report
Roundtable Summary: How Technology Can Accelerate Sustainable Finance
In a private roundtable at the Milken Institute Asia Summit 2022 in Singapore, the Milken Institute
gathered leading technologists, chief sustainability officers, large investors, and financial regulators for off-the-record discussions on environmental,
+ Read More
report
Projected Prevalence and Cost of Dementia: 2022 Update
The 2022 update on Alzheimer's Disease and Related Dementias (ADRD) highlights that:
report
Food and Agriculture in Asia: Investing in Resilience, Health, and Sustainability
As the world reels from multiple crises in rapid succession, the opportunities to set food systems
on a more sustainable and equitable path have never been more favorable, and in turn, the importance of multi-stakeholder convenings cannot be understated
+ Read More
report
Shared Responsibility: The Future of Green Financing
As the demand for green financing gains momentum, so too does the demand for complementary and prox
y industries, standards, and regulatory frameworks.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
report
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that
has challenged patients, their families, and the medical community for generations.
+ Read More
panel